This volume, The Basal Ganglia VII, is derived from the proceedings ofthe Seventh Triennial Meeting of the International Basal Ganglia Society (IBAGS). The Meeting was held from II - 15 February 2001 at The Copthorne Resort, Waitangi, Bay of Islands, New Zealand, the site of the signing of the Treaty ofWaitangi in 1840 and the traditional birth-place of the New Zealand Nation. As at previous Meetings, our aim was to hear and discuss new ideas and research developments on the basal ganglia and the implications of these findings for novel treatment strategies for basal ganglia disorders. The International Basal Ganglia Society (IBAGS) was founded in September 1983 when a small group of about 50 neuroscientists and clinicians with a passion for research on the basal ganglia met for a three day meeting in a small isolated seaside resort, Lome, 150km from Melbourne in Australia. The meeting was organised by John McKenzie and was so successful that the participants decided to establish IBAGS and to meet every 3 years at an isolated seaside resort in different countries of the world.
Section I: Neurotransmitters and Physiology. 1. DBS in Parkinsonian Subthalamic Nucleus: Electrophysiological and Biochemical Changes; A. Bassi, et al. 2. Action Selection in Parkinsonian Akinesia; T. Boraud, et al. 3. Different Patterns of Behavior and Gene Expression Induced by Chronic L-DOPA and A2A Antagonists plus L-DOPA Treatment in 6-Hydroxydopamine Lesioned Rats; A.R. Carta, et al. 4. Synchronization of Pallidal Activity in the MPTP Primate Model of Parkinsonism Is Not Limited to Oscillatory Activity; G. Heimer et al. 5. The High Frequency Discharge of Pallidal Neurons Disrupts the Interpretation of Pallidal Correlation Functions; I. Bar-Gad, et al. 6. The Role of Opioid Receptors in L-DOPA Induced Dyskinesia; C. de Groote, et al. 7. Coding of Behavioral Sequences in the Basal Ganglia; J.W. Aldridge, K.C. Berrigde. 8. Protection Against Nigrostriatal Dopamine Cell Death by Pedunculopontine Tegmental Nucleus Lesions; M. Takada, et al. 9. Influence of Deep Brain Stimulation on Striatal Dopamine Release and Metabolism in the 6-OHDA-Model of Parkinson's Disease; W. Meissner, et al. 10. Heterogeneity of Dopamine Release in the Primate Striatum; S.J. Cragg, C.J. Hille. 11. Enhanced Synchrony in the Primary Motor Cortex of MPTP Primates by Underlie Muscle Co-Contraction and Rigidity; J.A. Goldberg, et al. 12. Dopaminergic System in the Basal Ganglia of Sheep; J.S. McKenzie, et al. 13. The Roles of Metabotropic Glutamate Receptors in Modulating the Activity of the Subthalamic Nucleus; H. Awad-Granko, P.J. Conn. 14. Localization of Neuronal Nicotinic Acetylcholine Receptor Subunits in Rat Substantia Nigra and Dorsal Striatum; I.W. Jones, et al. 15. Cellular Localization of the GABA£Y/Y£ R1 Subunit in the Human Basal Ganglia; H.J. Waldvogel, R.L.M. Faull. 16. Partly Converging But Largely Segregated Corticostriatal Projections From the Primary Motor Cortex and the Supplementary Motor Area; A. Nambu, et al. 17. A Single Gene for Dystonia Involves Both or Either of the Two Striatal Pathways; M. Segawa, et al. 18. Thalamic Stimulation Promotes, While MFB Stimulation Inhibits, Calcium Oscillatory Activity in the Rat Striatum; M.D. Davis. 19. Striatal Tans Do not Report Prediction Error; G. Morris, et al. 20. False Detection of Dynamic Changes in Pallidal Neuron Interactions by the Joint Peri-Stimulus Histogram Method; D. Arkadit, et al. Section II: Ventral Striatum. 21. Core and Shell of the Nucleus Accumbens Are Interconnected via Intrastriatal Projections; W.C. van Dongen, H.J. Groenewegen. 22. Hippocampal Regulation of Prefrontal Cortex-Nucleus Accumbens Information Processing; Y. Goto, P. O'Donnell. 23. Pedunculopontine and Laterodorsal Tegmental Lesion Effects on Drug-Evoked Behaviours and Forebrain Dopamine Efflux; A.D. Miller, et al. Section III: Pharmacology. 24. New Insights into mGluRs Function in the Substantia Nigra Pars Compacta; E. Guatteo, et al. 25. Metabotropic Glutamate Receptors in the Globus Pallidus; O. Poisik, et al. 26. Abnormalities of Striatal NMDA Receptor-Mediated Transmission in Parkinson's Disease; P.J. Hallet, et al. 27. N-Terminal Tripeptide-1 (GPE) of IGF-1 Prevents the Loss Of TH Positive Neurons After 6-OHDA Induced Nigral Lesion in Rats; R. Krishnamurthi, et al. 28. Precise Localization of 5-HT2A Receptors in the Rat Substantia Nigra; G. Bacon, S. Totterdell. 29. Electrophysiological Effects of Cannabinoids in the Basal Ganglia; A.L. Muntoni, et al. Section IV: Neural Plasticity/Computational Models. 30. Self-Stimulation and Synaptic Plasticity; J.N.J. Reynolds, J.R. Wickens. 31. The Role of Dopamine Receptors in Regulating the Size of Axonal Arbours; D.I. Finkelstein, et al. 32. Responses to Partial Dopaminergic Lesion: Evidence For Compensatory Sprouting From The Ventral Striatum; S.N. Haber, D.D. Song. 33. Structural Plasticity in Parkinson's Disease; C.A. Ingham, et al. 34. Blood Vessels and Neurodegeneration in Parkinson's Disease; C. Barcia, et al. 35. The Robot Basal Ganglia; T.J. Precott, et al. 36. Functional Interactions Within The Subthalamic Nucleus; A. Gillies, et al. Section V: Circuitry. 37. The Functional Organisation of the Basal Ganglia: New Insights from Anatomical and Physiological Analyses; J.P. Bolam, et al. 38. Somatosensory Activation and Tissue Compartments in the Human Striatum; L.L. Brown, et al. 39. A Physiological Investigation of the Two Corticostriatal Systems in Rat Somatosensory Striatum; S. Ramanathan, et al. 40. Synaptic Convergence of Hippocampal and Prefrontal Cortical Afferents to the Ventral Striatum in Rat; S.J. French, et al. 41. Anatomical and Functional Relationships Between Intralaminar Thalamic Nuclei and Basal Ganglia in Monkeys; M. Sidebé, et al. 42. Local Connectivity Between Striatal Spiny Projection Neurons: a Re-Evaluation; D.E. Oorschot, et al. 43. Distribution of Pontomesencephalic Neurons Projecting to the Medullary Reticular Areas and Spinal Cord in Relation to the Pedunculopontine Nucleus in the Monkey; K. Nakano, et al. 44. Impact of Slow Cortical Rhythms on Basal Ganglia Output Nuclei Activity in Experimental Parkinsonism; K.Y. Tseng, et al. Section VI: Neuropathology. 45. Lesions of the Rat Globus Pallidus, Which Increase Subthalamic Nucleus Activity, Cause Dopamine Cell Death; A.K. Wright, et al. 46. Progressive Neurodegeneration in a New Mouse Model of Parkinson's Disease; S. Totterdell, et al. 47. Striosome and Matrix Pathology in Huntington Disease; J.C. Hedreen. 48. Immunohistochemical Localization of TATA-Binding Protein inn Huntington's Disease Cortex; W.M.C. van Room-Mom, et al. 49. Transcriptional Dysregulation in Huntington's Disease; J. Duce, et al. 50. The Role of Basal Ganglia in Visuo-Motor Coordination, Insights from Different Disease Conditions; S. Hocherman. 51. Torsina Immunoreactivity in Normal and DYT1 Brain; R.H. Walker, et al. 52. Anatomo-Chemical Organization of the Basal Ganglia Circuitry in the Normal and Parkinsonian States; C. François, et al. 53. Which Basal Ganglia Surgical Targets Ameliorate Parkinsonian Symptoms? J.M. Henderson, et al. 54. Effects of Pallidotomy and STN Stimulation on Reaching and Walking in Parkinson Disease; A.J. Bastian, et al. 55. Continuous Stimulation of the Globus Pallidus and Subthalamic Nucleus in Parkinson's Disease; J. Yelnik, et al. 56. Effects of High Frequency Stimulation in the Subthalamic Nucleus on Neuronal Firing in Parkinson's Disease Patients; J.O. Dostrovsky, et al. 57. High Frequency Stimulation of the Subthalamic Nucleus in Intact and Hemiparkinsonian Rats; P. Salin, et al. 58. Neurochemical Modifications induced by High Frequency Stimulation of the Subthalamic Nucleus in Rats; M. Savasta, et al. 59. Inactivating the Subthalamic Nucleus in the Rat Induces Various Cognitive Deficits and Motivational Exacerbation; C. Baunez, et al. 60. Responses of Neurons in Subthalamic Nucleus During Sequential Reaching in Patients with Parkinson's Disease; W.D. Hutchinson, et al. 61. Pallidothalamic Relation in Parkinson's Disease-Microrecording Study; C. Ohye, et al. Author Index. Subject Index.